About the Company
Assertio Therapeutics, Inc. is an American pharmaceutical company and is a major supplier of products for the treatment of neurology, pain, and diseases of the central nervous system. The company was founded in the year 1995 and is listed on NASDAQ as ASRT. There are several products approved by the United States Food and Drug Administration, and the company even announced its name change from Depomed, Inc. to Assertio Therapeutics, Inc. The company is headquartered in Newark, California, as a joint venture between Elan and Depomed. The company is known to improve the bioavailability of generic drugs through the usage of polymers that are usually used in the food and cosmetics industry to reduce the side effects and lower the doses that are necessary. The company also has its diabetes treatment, Glumetza, approved for adults in the United States.;
Organisation | Assertio Therapeutics Inc |